Ernexa Therapeutics
Ernexa Therapeutics is working on cutting-edge mRNA cell engineering technologies to fix cellular malfunction and treat a variety of therapeutic purposes. We and our strategic partners are developing novel nucleic acid and cell therapies that have the potential to significantly improve the health outcomes of people with significant unmet medical needs. We are dedicated to ensuring that patients and their families have access to life-changing treatments for critical illnesses. The IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. Brooklyn ImmunoTherapeutics serves patients and customers in the State of New York.
Domain
ernexatx.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$7.3M
Founded
1983
Tech Stack (7 technologies)
Frequently Asked Questions
What technologies does Ernexa Therapeutics use?+
Ernexa Therapeutics uses 7 technologies including Next.js, React, HSTS.
What industry is Ernexa Therapeutics in?+
Ernexa Therapeutics operates in the Biotechnology industry.
Where is Ernexa Therapeutics based?+
Ernexa Therapeutics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026